The multivariate survival analysis indicated that IGF1R-positive and IGFBP3-negative expression, along with lymph node metastasis, were independent prognostic indicators (Table 3). The gene discussed is IGFBP3; the disease is metastatic malignant neoplasm in the lymph nodes.